Sponsors

Next-generation DNA sequencing platform

Applied Biosystems has announced the worldwide commercial availability of the SOLiD system, the companyÆs nextgeneration DNA sequencing platform.

The SOLiD system is already enabling new ways of performing genetic analysis applications, which may set new standards for how scientists are able to approach complex challenges associated with understanding the biological basis for health and disease.

This new era of life-science research calls for technologies that can help scientists identify how genetic variation and patterns of gene expression contribute to disease, the manner in which individual genotypes impact, and how people may respond to various treatments. The SOLiD system is distinguished by unparallelled throughput, scalability, accuracy and application flexibility.

Applied Biosystems www.appliedbiosystems.com

Latest Issues

11th Digital Pathology & AI Congress: Europe

Hilton London Metropole, 255 Edgware Road, London, W2 1JU
11-12 December, 2024

Microbiology Society Annual Conference 2025

Liverpool Arena and Convention Centre
31 March - 3 April, 2025

BSMT Annual Microbiology Conference

RAF Museum, Hendon, London NW9 5LL
15 May, 2025

Ghent Pathology 2025

ICC Ghent, Belgium
24-26 June, 2025

37th European Congress of Pathology

ACV, Vienna, Austria
6 -10 September, 2025